Health Catalyst, Inc. expected to post earnings of 3 cents a share - Earnings Preview

Health Catalyst

04/08/2026 22:29

Health Catalyst, Inc. HCAT.OQ HCAT.O is expected to  show a fall in quarterly revenue when it reports  results on August 6 for the period ending June 30 2026
The South Jordan Utah-based  company is expected to report a 14.4% decrease in revenue to $69.059 million from $80.72 million a year ago, according to the mean estimate from 6 analysts, based on LSEG data.The company's guidance on May 11 2026, for the period ended June 30, was for revenue between $68.00 million and $70.00 million.
​LSEG's mean analyst estimate for Health Catalyst, Inc. is for earnings of 3 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Health Catalyst, Inc. is $2.25, about 1.8% above its last closing price of $2.21
The company's guidance on May 11 2026 for the period ended June 30 was for Earnings before Interest, Taxes, Depreciation and Amortization of between USD68 million and USD10 million.
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
0.01
0.02
0.02
Met
16.7
Dec. 31 2026
0.07
0.09
0.08
Missed
-12.1
Sep. 30 2025
0.06
0.06
0.06
Met
1.3​
Jun. 30 2025
0.03
0.03
0.04
Beat
18
​​Mar. 31 2025
0.00
0.00
0.01
Beat
400
Dec. 31 2024
0.07
0.07
0.04
Missed
-45.9​
Sep. 30 2024
0.10
0.10
0.07
Missed
-28.3
Jun. 30 2024
0.09
0.08
0.12
Beat
51.3
This summary was machine generated August 4 at 21:29 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)